Correlation Between BiOasis Technologies and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both BiOasis Technologies and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BiOasis Technologies and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between biOasis Technologies and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on BiOasis Technologies and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BiOasis Technologies with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BiOasis Technologies and Cadrenal Therapeutics,.
Diversification Opportunities for BiOasis Technologies and Cadrenal Therapeutics,
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BiOasis and Cadrenal is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding biOasis Technologies and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and BiOasis Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on biOasis Technologies are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of BiOasis Technologies i.e., BiOasis Technologies and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between BiOasis Technologies and Cadrenal Therapeutics,
Assuming the 90 days horizon biOasis Technologies is expected to generate 4.5 times more return on investment than Cadrenal Therapeutics,. However, BiOasis Technologies is 4.5 times more volatile than Cadrenal Therapeutics, Common. It trades about 0.05 of its potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about 0.11 per unit of risk. If you would invest 0.40 in biOasis Technologies on September 1, 2024 and sell it today you would lose (0.39) from holding biOasis Technologies or give up 97.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.21% |
Values | Daily Returns |
biOasis Technologies vs. Cadrenal Therapeutics, Common
Performance |
Timeline |
biOasis Technologies |
Cadrenal Therapeutics, |
BiOasis Technologies and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BiOasis Technologies and Cadrenal Therapeutics,
The main advantage of trading using opposite BiOasis Technologies and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BiOasis Technologies position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.BiOasis Technologies vs. Biotron Limited | BiOasis Technologies vs. Covalon Technologies | BiOasis Technologies vs. Mosaic Immunoengineering | BiOasis Technologies vs. Cellectis SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |